Clinical trial
AVANTI - Avelox® in Acute Exacerbations of Chronic Bronchitis
NCT00846911 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- AVANTI - Avelox® in Acute Exacerbations of Chronic Bronchitis
- Lead sponsor
- Bayer
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2008
- Completion date
- April 30, 2010
- Enrollment
- 2,672 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.